Noninvasive quantification of the differential portal and arterial contribution to the liver blood supply from PET measurements using the /sup 11/C-acetate kinetic model

Our recent research has demonstrated that /sup 11/C-acetate could be a complementary tracer to /sup 18/Ffluorodeoxyglucose (FDG) in positron emission tomography (PET) imaging of hepatocellular carcinoma (HCC). In our previous modeling study, a three-compartment four-parameter model with a fixed contribution ratio of the liverʹs two blood supplies was proposed to characterize the kinetic behavior of /sup 11/C-acetate in liver. However, in real pathology, both tumor and nontumor liver tissue can be heterogeneous in the distribution and proportion of the two blood supplies. To further improve the accuracy of quantitative analysis, the actual proportion of the hepatic artery and portal vein (PV) in different regions of interest (ROIs) was investigated in this study. An extra parameter a/sub v/ was included in the model input function to describe the contribution of PV to the liver. Ten ROIs extracted from six patients were used to test the models with fixed/nonfixed weighted dual-input function. The weighted nonlinear least squares algorithm was used to estimate all of the parameters. Evaluation of the adequacy of the two models was conducted and the computer simulation was performed to test the estimation accuracy of the new model. The forward clearance K was also estimated by the linear Patlak method. The results show that the model with parameter a/sub v/ in the input function was more suitable for mapping the tracer time activity curves. Moreover, the estimated a/sub v/ value fits the practical physiological and pathological conditions well and could be a potential candidate to provide useful additional diagnostic information for the early detection of hepatic metastases.